Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 27,007 US PATENTS IN FORCE
- 51,295 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 225,611 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| RE50189 | Long term treatment of HIV-infection with TMC278 | Sep 13, 21 | Oct 29, 24 | Janssen Sciences Ireland Unlimited Company |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0365,814 | MICROBIAL COMPOSITIONS AND METHODS FOR RUMINANT HEALTH AND PERFORMANCE | Nov 30, 23 | Nov 07, 24 | Native Microbials, Inc. |
| 2024/0366,857 | STERILIZABLE PRE-FILLED PHARMACEUTICAL PACKAGES COMPRISING A LIQUID FORMULATION OF A VEGF-ANTAGONIST | Feb 14, 24 | Nov 07, 24 | Not available |
| 2024/0366,964 | LOW INTENSITY FOCUSED ULTRASOUND FOR TREATING CANCER AND METASTASIS | May 08, 24 | Nov 07, 24 | Not available |
| 2024/0366,972 | Chimeric Antigen Receptor-Modified NK-92 Cells | Jul 05, 24 | Nov 07, 24 | ImmunityBio, Inc. |
| 2024/0366,517 | METHODS AND COMPOSITIONS FOR DENDRITIC CELL TARGETING VACCINES | Apr 08, 24 | Nov 07, 24 | Not available |
| 2024/0366,527 | HONOKIOL LIPOSOME TRANSDERMAL GEL, PREPARATION METHOD AND USE THEREOF | Jul 17, 24 | Nov 07, 24 | Not available |
| 2024/0366,529 | SUBSTITUTED ALKYLPHENOLS AS HCN1 ANTAGONISTS | Apr 26, 23 | Nov 07, 24 | Cornell University |
| 2024/0366,531 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND DISORDERS | May 01, 24 | Nov 07, 24 | Not available |
| 2024/0366,533 | Sublingual Epinephrine Tablets | Jul 19, 24 | Nov 07, 24 | Not available |
| 2024/0366,539 | METHODS FOR TREATING AUTISM SPECTRUM DISORDERS | Sep 02, 22 | Nov 07, 24 | Not available |
| 2024/0366,541 | METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT | May 13, 24 | Nov 07, 24 | Not available |
| 2024/0366,543 | METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA | Apr 06, 22 | Nov 07, 24 | Not available |
| 2024/0366,545 | ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | Aug 09, 22 | Nov 07, 24 | Not available |
| 2024/0366,549 | MONOGLYCERIDE USE IN ANIMALS | Jul 18, 24 | Nov 07, 24 | CAN TECHNOLOGIES, INC. |
| 2024/0366,551 | MIXTURES AND COMPOSITIONS COMPRISING SULFORAPHANE AND GLYCINE | Aug 16, 22 | Nov 07, 24 | Not available |
| 2024/0366,555 | SELECTIVE MTORC2 INHIBITOR AND USES THEREOF | Apr 11, 22 | Nov 07, 24 | Not available |
| 2024/0366,559 | METHODS OF TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Jan 11, 24 | Nov 07, 24 | SUMITOMO PHARMA AMERICA, INC. |
| 2024/0366,561 | SYSTEM AND ASSAY FOR MONITORING PRODUCTION/RELEASE OF MEMBRANE-LYTIC TOXINS IN BACTERIA AND COMPOUNDS FOR MODULATING SAME | Jul 18, 24 | Nov 07, 24 | Not available |
| 2024/0366,563 | METHODS OF TREATING MALIGNANT LYMPHOPROLIFERATIVE DISORDERS | Apr 09, 24 | Nov 07, 24 | Not available |
| 2024/0366,565 | Use of Verteporfin to Modulate Wound Healing After an Ocular Surgical Procedure or Ocular Injury | Sep 09, 22 | Nov 07, 24 | Not available |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)